This site is intended for health professionals only!

Published on 22 June 2007

Share this story:
Twitter
LinkedIn
Share
RELATED ARTICLES
Panitumumab found effective and well tolerated in chemotherapy-refractory mCRC
Bid to reduce use of antibiotics
14% of healthcare professionals feel sufficiently equipped to address prostate cancer patients’ QoL issues
Cancer Research UK, LifeArc and Ono Pharma form cancer therapy alliance
Boehringer Ingelheim and Eli Lilly announce data on diabetes portfolio

US go-ahead for Exforge

teaser

Novartis has received US approval for Exforge



Most read

1
Feedback: Automation systems in your hospital
2
Helapet introduce new, improved 20mm Vented Vial Adapter
3
User-friendly osteoporosis therapy launched
4
Merck agrees huge Vioxx settlement
5
Janssen-Cilag’s Stelara approved by NICE



Latest Issue

Read the latest issue >
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
Share this story:
Twitter
LinkedIn
Share
RELATED ARTICLES
Warning over risk of medical abbreviations
24th Annual EAU Congress key messages
Novo Nordisk sets up joint research unit in China
Acomplia may face rough ride
Drug-resistant tuberculosis prompts caution